Clinical Research
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 21, 2005; 11(43): 6815-6822
Published online Nov 21, 2005. doi: 10.3748/wjg.v11.i43.6815
Table 1 List of primers
TargetPrimerSequence (5’- 3’)Product
genesize (bp)
CagA-F1AACAGGACAAGTAGCTAGCC
CagA1CagA-R1TATTAATGCGTGTGTGGCTG701
CagA-F2GATAACAGGCAAGCTTTTGA
CagA2CagA-R2CTGCAAAAGATTGTTTGGCAGA349
CagAP-F1GTGGGTAAAAATGTGAATCG
CagAP1CagA-R1TATTAATGCGTGTGTGGCTG730
CagAP-F2CTACTTGTCCCAACCATTTT
CagAP2CagA-R2CTGCAAAAGATTGTTTGGCAGA1 181
CagE-F1GCGATTGTTATTGTGCTTGTAG
CagECagE-R1GAAGTGGTTAAAAAATCAATGCCCC329
CagT-F1CCATGTTTATACGCCTGTGT
CagTCagT-R1CATCACCACACCCTTTTGAT301
LEC-F1ACATTTTGGCTAAATAAACGCTG
LEC-1LEC-R1TCTCCATGTTGCCATTATGCT384
LEC-F2ATAGCGTTTTGTGCATAGAA
LEC-2LEC-R2ATCTTTAGTCTCTTTAGCTT877
Table 2 Relationship between the presence of cag-PAI and the clinical status
Clinical status (n)Intact PAI (%)cag-PAI typeCompletely deleted
Partially deletedPAI (%)
PAI (%)
DU (58)4 (6.9)54 (93.1)0
GU (46)45 (97.8)1 (2.2)0
NUD (56)4 (7.1)52 (92.9)0
GC (14)12 (85.7)2 (14.3)0
Total (174)65 (37.4)109 (62.6)0
Table 3 cagA status of H pylori isolates
Clinical status (n)cagA +ve (%)Partial cagA +ve (%)cagA–ve (%)
DU (58)8 (13.8)46 (79.3)4 (6.9)
GU (46)45 (97.8)1 (2.2)0
NUD (56)4 (7.1)52 (92.9)0
GC (14)12 (85.7)2 (14.3)0
Total (174)69 (39.7)101 (58)4 (2.3)
Table 4 Distribution of cagA gene and cagA promoter in H pylori isolates
Clinical status (n)A1+A2 (%)AP1+AP2 (%)
DU (58)43 (74.1)8 (13.8)
GU (46)45 (97.8)46 (100)
NUD (56)32 (57.1)6 (10.7)
GC (14)14 (100)12 (85.7)
Total (174)134 (77)72 (41.4)
Table 5 Distribution of cagE, T, LEC1, and LEC2 in H pylori isolates
Clinical status (n)cagE (%)cagT (%)LEC1 (%)LEC2 (%)
DU (58)47 (81)56 (96.5)44 (75.8)33 (56.8)
GU (46)46 (100)46 (100)46 (100)46 (100)
NUD (56)36 (64.2)36 (64.2)38 (67.8)18 (32.1)
GC (14)14 (100)14 (100)14 (100)14 (100)
Total (174)143 (82.1)152 (87.3)142 (81.6)111 (63.7)
Table 6 Frequency of atrophy, metaplasia, and dysplasia in chronic gastritis subjects
ClinicalAcuteChronic gastritis
status (n)gastritis (%)SuperficialGastritis withGastritis withGastritis with
gastritisatrophy (%)metaplasia (%)dysplasia (%)
DU (58)052 (89.7)2 (3.4)4 (6.9)0
GU (46)09 (19.6)13 (28.3)14 (30.4)10 (21.7)
NUD (56)051 (91.1)5 (8.9)00
Total (160)0112 (70)20 (12.5)18 (11.25)10 (6.25)
Table 7 Histological status of subjects with intact cag-PAI (n = 65) and partial cag-PAI (n = 109)
Cag-typeChronic gastritis
Gastric carcinoma
(n)Superficial gastritisGastritis with atrophy
Gastritis with metaplasia (%)
Gastritis with dysplasia(%)
Intestinal (%)
Diffuse (%)
(%)(%)Ty-1Ty-2Ty-3Low gradeHigh grade
Intact (65)8 (12.3)17 (26.1)b001801012b0
-27.7-15.4-18.5
Partial (109)104 (95.4)3 (2.8)000002 (1.8)0
Table 8 Correlation of the histological status of the subjects with intact and partially deleted cag-PAI from varied disease status
Clinical statusChronic gastritis
Gastric carcinoma
(n)cag statusSuperficial gastritisGastritis with atrophy (%)Gastritis with metaplasia (%)
Gastritis with dysplasia (%)
Intestinal (%)Diffuse (%)
(n)(%)Ty-1Ty-2Ty-3Low gradeHigh grade
DU (58)Intact (4)00004 (100)0000
Partial (54)52 (96.3)2 (3.7)0000000
GU (46)Intact (45)8(17.8)a13 (28.9)0014 (31.1)010 (22.2)00
Partial (1)1 (100)00000000
NUD (56)Intact (4)04(100)a0000000
Partial (52)51 (98.1)1 (1.9)0000000
GC (14)Intact (12)000000012 (100)b0
Partial (2)00000002 (100)0